David Abrams - Abrams Capital Management

Holding/activity history for  Keryx Biopharmaceuticals Inc. (KERX)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2018   Q4 0 0 Sell 100.00% 0.82
2018   Q3 9,108,867 0.82 Reduce 8.45% 0.08 $3.40
2018   Q2 9,950,055 1.04 Add 2.38% 0.02 $3.76
2018   Q1 9,719,176 1.25 $4.09
2017   Q4 9,719,176 1.52 Add 69.94% 0.63 $4.65
2017   Q3 5,719,176 1.58 $7.10
2017   Q2 5,719,176 1.64 $7.23
2017   Q1 5,719,176 1.35 $6.16
2016   Q4 5,719,176 1.23 $5.86
2016   Q3 5,719,176 1.51 $5.31
2016   Q2 5,719,176 1.98 $6.62
2016   Q1 5,719,176 1.26 Add 3.99% 0.05 $4.67
2015   Q4 5,500,000 1.52 Add 10.00% 0.14 $5.05
2015   Q3 5,000,000 1.26 Buy 1.26 $3.52